Dayton Center for Neurological Disorders

Centerville, Ohio 45459

1 studies enrolling now · 17 studies all time

What they study most

Adult Lower Limb Spasticity, Alzheimer Disease, Constipation, Episodic Migraine, Generalized Myasthenia Gravis, Idiopathic Parkinson Disease, Menstrual Migraine, Migraine, Mild Cognitive Impairment, Parkinson Disease, Parkinson Disease Psychosis, Parkinson's Disease

Studies at this site

• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine — Recruiting now
• A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis — Running, not enrolling
• A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development — Running, not enrolling
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab — Running, not enrolling
• A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) — Running, not enrolling
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab — Stopped early
• Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) — Completed
• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
• Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide) — Completed
• Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort — Completed
• Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine — Stopped early
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study — Stopped early
• Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif® — Completed